Plant Health Care - PREtec Products Submitted for Regulatory Approval
25/09/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230925:nRSY4159Na&default-theme=true
RNS Number : 4159N Plant Health Care PLC 25 September 2023
25 September 2023
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
New PREtec Products Submitted for Regulatory Approval
PHC25279 and PHC68949 submitted for approval in Mexico
Plant Health Care(®) (AIM: PHC.L), a leading provider of novel
patent-protected biological products to global agriculture markets, is pleased
to announce it has submitted applications to the Mexican regulatory agency
for approval to commercialize the newest products derived from the Company's
PREtec technology platform (Vaccines for Plants(TM)), PHC25279 and PHC68949,
for use on major crops.
PHC25279 helps control a broad spectrum of plant diseases when used as part of
an integrated disease control program and is expected to find immediate
application for the control of Gray Mold (Botrytis cinerea) in berries, Downy
Mildew (Pseudoperonospora cubensis) in cucurbits such as cucumbers and Late
Blight (Phytothphora infestans) in tomatoes and other Solanaceae crops. The
current planted area in Mexico for berries totals 55,000 hectares. The
production of cucumbers in Mexico is expected to reach 1.02 million metric
tons by 2026. Additional PHC25279 product label claims against various other
plant pathogens will be added in the future.
PHC68949 is a novel product that amplifies a plant's natural defense pathways
to provide protection against plant parasitic nematodes which damage plant
roots and limit crop yield. As a next generation bionematicide, PHC68949
increases plant health and yield across a wide range of commercial crops.
Results from field studies confirm the efficacy from foliar applications of
PHC68949 is comparable to synthetic chemical nematicides and superior to
current biological products. PHC68949 is expected to find immediate use in
tomatoes, eggplants, peppers and other crops within the Solanaceae family and
in cucurbits to protect against yield and quality losses caused by root knot
nematodes (Meloidogyne spp.) and other pathogenic nematode species. Mexico's
2023 fresh tomato production is forecasted to reach 3.4 million metric tons
(MMT). Additional PHC68949 product label claims against plant parasitic
nematodes will be added in the future.
Both products are based on the Company's PREtec technology platform
(Vaccines for Plants(TM)). Derived from natural proteins, PREtec is an
environmentally friendly technology which stimulates plant defense and
pathogen resistance mechanisms within plants, resulting in improved crop
growth and quality along with the ability to withstand a variety of abiotic
stresses. PHC25279 and PHC68949 represent unique products from this platform
which provide specific benefits of improved disease and nematode control,
plant health and yield. PREtec peptides are compatible with mainstream
agricultural practices and common IPM (Integrated Pest Management) and
resistance management practices.
The regulatory process in Mexico for agricultural products involves a detailed
and comprehensive review of standard data requirements. Upon approval, the
Federal Committee for Protection from Sanitary Risks (COFEPRIS) will issue
Federal Registration. Although COFEPRIS does not commit to a specific
timeline for granting regulatory licenses, the Company expects the review to
start soon and to receive regulatory approvals within 1-2 years.
Plant Health Care continues to expand into new markets around the world and
is growing its relationships with major global distribution partners. The
Company is on track to achieve revenue of $30 million by 2025 through the
launch of new products and continued organic business growth through current
and future distributor relationships.
Jeff Tweedy, CEO of Plant Health Care, said: ‟Ranking 11(th) in global
food production, Mexico provides a tremendous opportunity for the adoption
of these new products to support sustainable agriculture. Building on the
current success of our ProAct biostimulant, our dedicated team in Mexico is
already laying the groundwork for the commercial launch of these two new
products once the regulatory licenses are granted. These registration
submissions are key steps for Plant Health Care in meeting our $30
million revenue target by 2025."
For further information, please contact:
Plant Health Care plc +1 919 926 1600
Jeff Tweedy, CEO
Cavendish Securities plc - Nomad & Broker +44 (0) 131 220 9771
Neil McDonald / Pete Lynch
SEC Newgate - Financial Communications +44 (0)7540 106 366
Robin Tozer / Harry Handyside / George Esmond phc@secnewgate.co.uk (mailto:phc@secnewgate.co.uk)
About Plant Health Care
Plant Health Care offers products to improve the health, vigour and yield of
major field crops such as corn, soybeans, potatoes and rice, as well as
specialty crops such as fruits and vegetables. We operate globally through
subsidiaries, distributors and supply agreements with major industry partners.
Our innovative, patent-protected biological products help growers to protect
their crops from stress and diseases, and to produce higher quality fruit and
vegetables, with a favourable environmental profile.
Find out more at www.planthealthcare.com (http://www.planthealthcare.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAPBSGDCBSDDGXD